Intrapulmonary shunting in primary pulmonary hypertension - An observation in two patients treated with epoprostenol sodium

Simple item page
dc.contributor.authorCastro, PF
dc.contributor.authorBourge, RC
dc.contributor.authorMcGiffin, DC
dc.contributor.authorBenza, RL
dc.contributor.authorFan, P
dc.contributor.authorPinkard, NB
dc.contributor.authorMcGoon, MD
dc.date.accessioned2025-01-21T01:32:37Z
dc.date.available2025-01-21T01:32:37Z
dc.date.issued1998
dc.description.abstractContinuous intravenous infusion of epoprostenol sodium in selected patients with primary pulmonary hypertension improves symptoms and survival. This report describes two patients with primary pulmonary hypertension treated with epoprostenol in whom intrapulmonary shunting and severe hypoxemia occurred. Intrapulmonary shunting was confirmed by contrast echocardiography showing delayed appearance of bubbles in the left cardiac chambers after peripheral venous injection of agitated saline solution.
dc.fuente.origenWOS
dc.identifier.issn0012-3692
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/97294
dc.identifier.wosidWOS:000074837100059
dc.issue.numero1
dc.language.isoen
dc.pagina.final336
dc.pagina.inicio334
dc.revistaChest
dc.rightsacceso restringido
dc.subjectcontrast echocardiography
dc.subjectepoprostenol
dc.subjecthypoxemia
dc.subjectintrapulmonary shunting
dc.subjectprimary pulmonary hypertension
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleIntrapulmonary shunting in primary pulmonary hypertension - An observation in two patients treated with epoprostenol sodium
dc.typeartículo
dc.volumen114
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files
Collections
Artículos de revistas